Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00573131
What this trial is testing

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

Who this might be right for
Esophageal CancerAdenocarcinoma of the EsophagusSquamous Cell Carcinoma
Boston Scientific Corporation 137
Testing effectiveness (Phase 2)Looking for participantsNCT05745857
What this trial is testing

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

Who this might be right for
Barrett's Esophagus Without DysplasiaBarrett Oesophagitis With DysplasiaEsophageal Adenocarcinoma
University Medical Center Groningen 25
Early research (Phase 1)Looking for participantsNCT07481357
What this trial is testing

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Who this might be right for
Gastric (Stomach) CancerGastroEsophageal CancerPancreatic Ductal Adenocarcinoma (mPDAC)
Dong-A ST Co., Ltd. 51
Large-scale testing (Phase 3)Study completedNCT00002883
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
UNICANCER 250
Testing effectiveness (Phase 2)Study completedNCT02735239
What this trial is testing

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Who this might be right for
Esophageal Cancer
Ludwig Institute for Cancer Research 73
Large-scale testing (Phase 3)WithdrawnNCT04029857
What this trial is testing

Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Pathologic Stage III Esophageal Adenocarcinoma AJCC v8+12 more
M.D. Anderson Cancer Center
Not applicableUnknownNCT00963092
What this trial is testing

Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
Cancer Research UK 4,000
Testing effectiveness (Phase 2)Study completedNCT00003087
What this trial is testing

Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00978549
What this trial is testing

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer+2 more
Cambridge University Hospitals NHS Foundation Trust 320
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT01077999
What this trial is testing

Chemoradiation and Panitumumab for Esophageal Cancer

Who this might be right for
Squamous Cell CarcinomaAdenocarcinomaEsophageal Cancer+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379596
What this trial is testing

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

Who this might be right for
Gastric Cancer
AstraZeneca 452
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Not applicableUnknownNCT00516347
What this trial is testing

Studying Genes for Barrett's Esophagus in Brothers and Sisters

Who this might be right for
Esophageal CancerPrecancerous Condition
Medical Research Council 400
Testing effectiveness (Phase 2)Study completedNCT00002984
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06933966
What this trial is testing

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaNon Metastatic Disease
Centre Leon Berard 120
Testing effectiveness (Phase 2)Ended earlyNCT00004897
What this trial is testing

Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT07070466
What this trial is testing

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Who this might be right for
Stomach Cancer Stage IVEsophagus CancerStomach Cancer
Massachusetts General Hospital 40
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Large-scale testing (Phase 3)Study completedNCT02178956
What this trial is testing

BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Sumitomo Pharma America, Inc. 714
Next Page